hVIVO’s Dr Rob Lambkin-Williams making 2 oral and 2 poster presentations at Macrae Foundation International Symposium on Respiratory Viral Infections, Lisbon, Portugal, March 2016

March 3, 2016 11:37 am

XVII International Symposium on Respiratory Viral Infections, March 31 – April 2, 2016, Lisbon Marriott Hotel, Lisbon, Portugal

Dr Rob Lambkin-Williams, Executive Scientific Advisor at hVIVO, will be making two oral presentation at the Macrae Foundation’s International Symposium on Respiratory Viral Infections in Lisbon, Portugal. In addition, Rob will present two scientific posters at the event.

The Macrae Foundation’s mission is generating collaboration and innovation to advance medical and scientific research in the field of infectious disease and their intervention strategies. This 3-day symposium serves as a catalyst for discussing and debating cutting edge information, with the aim of creating an interconnected flow of worldwide research and propelling new directions in research for science, industry and government funding agencies.

This Symposium will present the practical aspects of current treatment and future prospects for respiratory viral infectious diseases through invited talks, oral abstracts and poster abstract presentations.

Dr Rob Lambkin-Williams will be presenting on Friday 1st April with the title of his presentation: “Reinventing the Common Cold Institute for the 21st Century” and also on Saturday 2nd April with the title “The Use of the Human Viral Challenge Model as Part of a Long Term Program of Work to Better Understand Respiratory Viruses and their Interaction with the Human Host”.

Additionally, Rob will present two posters; “Novel RSV Stabilisation Matrix Validated for Short and Long Term Storage and Multiple Freeze Thaws” and “Development of ViruSpot Imaging Technology for High Throughput Measurement of RSV-Neutralising Antibodies During Vaccine Trials”.

Commenting on the imminent event Dr Lambkin-Williams said: “I am delighted to be giving two talks at such an important conference, in the first I will put into context the use of the Human Viral Challenge Study in the 21st century and its utility, building on the experience of the Common Cold Institute during the 20th century. In the second talk I will describe a programme of work that used the model with great effect, conducted with Duke University, that explored the interaction between three respiratory viruses and the human host. I am also looking forward to presenting two posters illustrating other aspects of our pioneering work.”

Accompanying Rob at the event will be Amanda Higgins and Melissa Wagner, hVIVO Business Development Directors, and if you would like to make contact with either Rob, Amanda or Melissa before or during the event, please use the contact form below.

Find out more about XVII International Symposium on Respiratory Viral Infections 2016 event in Lisbon here.

Comments are closed here.